title: Obesity-related hypertension.
abstract: Obesity-associated arterial hypertension is characterized by activation of the sympathetic nervous system, activation of the renin-angiotensin system, and sodium retention, among other abnormalities. In this review, the following 3 facets of the obesity/hypertension nexus will be discussed: the potential mechanisms by which obesity can lead to elevated arterial pressure, the interaction of obesity with the sequelae of hypertension, and the therapies that are believed to optimally treat obesity-related hypertension.
authors: Hypertension Section, Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA.
authors: Richard N
authors: RN
authors: Re
references: Curr Hypertens Rep. 2007 Nov;9(5):368-72
references: 18177582
references: J Hypertens. 2008 May;26(5):831-43
references: 18398321
references: Am J Med Sci. 2002 Sep;324(3):127-37
references: 12240710
references: J Neuroendocrinol. 2008 May;20 Suppl 1:58-62
references: 18426501
references: Biochem Biophys Res Commun. 2006 Jan 13;339(2):633-41
references: 16310163
references: Med Clin North Am. 1987 Sep;71(5):877-95
references: 3306208
references: Cardiol Rev. 2002 May-Jun;10(3):127-38
references: 12047791
references: Am J Hypertens. 1989 Jul;2(7):573-4
references: 2667574
references: Curr Hypertens Rep. 2008 Jun;10(3):241-7
references: 18765097
references: Curr Pharm Des. 2004;10(29):3621-37
references: 15579059
references: Am J Hypertens. 2001 Jul;14(7 Pt 1):694-8
references: 11465655
references: Am J Cardiol. 2007 Nov 1;100(9):1460-4
references: 17950808
references: J Neuroendocrinol. 2008 May;20 Suppl 1:110-5
references: 18426509
references: N Engl J Med. 2009 Jan 1;360(1):44-52
references: 19092146
references: Curr Hypertens Rep. 2007 Dec;9(6):491-7
references: 18367013
references: Curr Opin Cardiol. 2001 Nov;16(6):317-27
references: 11704700
references: Curr Hypertens Rep. 2000 Apr;2(2):139-47
references: 10981140
references: Expert Rev Cardiovasc Ther. 2008 Mar;6(3):289-303
references: 18327991
references: Diabetes Care. 2002 Nov;25(11):2088-97
references: 12401761
references: J Neuroendocrinol. 2008 May;20 Suppl 1:63-8
references: 18426502
references: Circulation. 1994 Jan;89(1):493-8
references: 8281685
references: Clin Exp Pharmacol Physiol. 2006 Sep;33(9):857-62
references: 16922821
references: Am J Cardiol. 2008 Jun 1;101(11):1621-5
references: 18489940
references: Physiol Genomics. 2004 Sep 16;19(1):32-40
references: 15226482